CNS inflammation in nervous and mental disease
CNS inflammation in nervous and mental disease
批准号:
7900468
负责人:
Joel S Pachter
金额:
$36.91万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-08-01 至 2012-07-31
关键词:
Active ImmunizationAdhesionsAnimal ModelAnimalsAstrocytesBloodBlood - brain barrier anatomyBlood CirculationBrainC57BL/6 MouseCCL2 geneCaveolaeCellsCentral Nervous System DiseasesClinicalCommunicationComprehensionCytoplasmDiseaseEncephalomyelitisEndothelial CellsExperimental Autoimmune EncephalomyelitisExtravasationFoundationsFundingFutureGene DeletionGlycocalyxGrantImmunoelectron MicroscopyInflammationInflammatoryInvadedKnock-outKnockout MiceLaboratoriesLeftLeukocytesMicrogliaMonocyte Chemoattractant Protein-1Mononuclear LeukocytesMovementMultiple SclerosisMusNervous system structureNeuraxisNeuronsPathogenesisPathway interactionsPeptidesPhenotypePlayProcessProductionPsyche structureResearchResolutionRoleSiteSocietiesSourceSpinal CordSurfaceTechnologyTestingTherapeuticbasecell typechemokinedesignextracellularfootinsightneuroinflammationneuropathologyneurovascular unitnoveloligodendrocyte-myelin glycoproteinprotein distributionresearch study
中文摘要
趋化因子CCL2被认为是多发性硬化症(MS)的重要因素,并在
实验性自身免疫性脑脊髓炎动物模型的主要致病作用
对于MS来说,CCL2在EAE中非冗余地发挥作用,促进破坏性的积累
中枢神经系统(CNS)中的白细胞,以及可能的其他表现
神经炎,既不是这种趋化因子的致病来源(S),也不是它的部位(S)和
作用机理(S),都是已知的。当星形胶质细胞和内皮细胞被识别时
作为EAE期间CCL2的主要来源,目前还没有关于是否以及如何协调的描述
这两个细胞中的任何一个产生CCL2会导致白细胞外渗和侵袭
中枢神经实质。这一缺陷在理解MS/EAE方面留下了重大空白
发病机制,并严重影响MS的新治疗方法,因为抗CCL2的潜力
治疗在很大程度上依赖于有效地破坏特定的趋化素池(S)
负责疾病活动。因此,设计实验是为了开始测试
广义假设:CCL2的细胞特异性释放调节不同方面的
EAE期间的神经炎症。目标1将专注于执行第一个高分辨率分析
CCL2蛋白在整个EAE过程中在中枢的分布,这将提供洞察力
进入中枢来源的CCL2和血液传播的那些通讯通路
对于引导外渗至关重要的白细胞。然后,Aim 2将采用两种新颖的、细胞条件的
CCL2基因敲除系-星形胶质细胞或内皮细胞中CCL2的靶向消除-TO
确定这些细胞类型中的每一种对临床疾病的各自贡献。这些
实验将为未来的研究提供基础,通过以下方式进一步解决机制
哪种CCL2促进白细胞外溢进入中枢神经系统,并突出治疗途径
在中枢神经系统炎症性疾病期间最有效地干扰CCL2的作用。
英文摘要
The chemokine CCL2 is considered a significant factor in multiple sclerosis (MS), and plays a
primary pathogenic role in experimental autoimmune encephalomyelitis (EAE), an animal model
for MS. Though CCL2 nonredundantly functions in EAE to promote accumulation of destructive
leukocytes in the central nervous system (CNS), as well as possibly other manifestations of
neuroinflammation, neither the pathogenic source(s) of this chemokine, nor its site(s) and
mechanism(s) of action, are known. And while astrocytes and endothelial cells are recognized
as major sources of CCL2 during EAE, no descriptions have yet reconciled whether and how
production of CCL2 by either of these cells leads to leukocyte extravasation and invasion of the
CNS parenchyma. This deficiency leaves a significant void in understanding MS/EAE
pathogenesis, and seriously impacts novel treatments for MS, as the potential of anti-CCL2
therapy is critically dependent on effectively disrupting the specific chemokine pool(s)
responsible for disease activity. Accordingly, experiments are designed to begin testing the
following broad hypothesis: Cell-specific release of CCL2 regulates discrete aspects of
neuroinflammation during EAE. Aim 1 will focus on performing the first high-resolution analysis
of CCL2 protein distribution in the CNS throughout the course of EAE, which will provide insight
into those pathways of communication between centrally derived CCL2 and blood-borne
leukocytes critical for guiding extravastion. Aim 2 will then employ two novel, cell-conditional
CCL2 knockout lines - suffering targeted CCL2 elimination in astrocytes or endothelial cells - to
determine the respective contributions of each of these cell types to clinical disease. These
experiments will provide a foundation for future studies to further resolve the mechanisms by
which CCL2 promotes leukocyte extravastion into the CNS, and highlight therapeutic avenues
to most efficiently disrupt CCL2 action during CNS inflammatory disease.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Novel 3D analysis of Claudin-5 reveals significant endothelial heterogeneity among CNS microvessels.
DOI:
10.1016/j.mvr.2012.12.001
发表时间:
2013-03
期刊:
MICROVASCULAR RESEARCH
影响因子:
3.1
作者:
[Paul, Debayon, Cowan, Ann E., Ge, Shujun, Pachter, Joel S.]
通讯作者:
Pachter, Joel S.
Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry
-
批准号:10549824
-
项目类别:
-
资助金额:$24.6万
-
财政年份:2022
-
负责人:Joel S Pachter
-
依托单位:
Detailed molecular and structural characterization of the meninges: an approach combining proteomics and Imaging Mass Cytometry
-
批准号:10462994
-
项目类别:
-
资助金额:$20.5万
-
财政年份:2022
-
负责人:Joel S Pachter
-
依托单位:
Regulation of CNS leukocyte extravasation
-
批准号:9908187
-
项目类别:
-
资助金额:$37.16万
-
财政年份:2017
-
负责人:Joel S Pachter
-
依托单位:
Regulation of CNS leukocyte extravasation
-
批准号:10163922
-
项目类别:
-
资助金额:$36.72万
-
财政年份:2017
-
负责人:Joel S Pachter
-
依托单位:
LCM Instrument, Arcturus XT-TI
-
批准号:8640630
-
项目类别:
-
资助金额:$21.18万
-
财政年份:2014
-
负责人:Joel S Pachter
-
依托单位:
Microvascular endothelial cell heterogeneity in the central nervous system
-
批准号:7177092
-
项目类别:
-
资助金额:$19.11万
-
财政年份:2007
-
负责人:Joel S Pachter
-
依托单位:
Microvascular endothelial cell heterogeneity in the central nervous system
-
批准号:7342513
-
项目类别:
-
资助金额:$16.19万
-
财政年份:2007
-
负责人:Joel S Pachter
-
依托单位:
CNS Inflammation in Nervous and Mental Disease
-
批准号:6779098
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS INFLAMMATION IN NERVOUS AND MENTAL DISEASE
-
批准号:2392989
-
项目类别:
-
资助金额:$24.01万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS INFLAMMATION IN NERVOUS AND MENTAL DISEASE
-
批准号:2675380
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS INFLAMMATION IN NERVOUS AND MENTAL DISEASE
-
批准号:2255121
-
项目类别:
-
资助金额:$20.81万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS Inflammation in Nervous and Mental Disease
-
批准号:6650182
-
项目类别:
-
资助金额:$25.38万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS Inflammation in Nervous and Mental Disease
-
批准号:6928522
-
项目类别:
-
资助金额:$21.75万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS INFLAMMATION IN NERVOUS AND MENTAL DISEASE
-
批准号:2890716
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS Inflammation in Nervous and Mental Disease
-
批准号:6384143
-
项目类别:
-
资助金额:$24.99万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
CNS Inflammation in Nervous and Mental Disease
-
批准号:6538744
-
项目类别:
-
资助金额:$25.38万
-
财政年份:1996
-
负责人:Joel S Pachter
-
依托单位:
AUTOREGULATION OF TUBULIN GENE EXPRESSION
-
批准号:3040229
-
项目类别:
-
资助金额:$2.6万
-
财政年份:1986
-
负责人:Joel S Pachter
-
依托单位:
AUTOREGULATION OF TUBULIN GENE EXPRESSION
-
批准号:3040228
-
项目类别:
-
资助金额:$2.5万
-
财政年份:1985
-
负责人:Joel S Pachter
-
依托单位:
海外基金